AVIR News and Press, Atea Pharmaceuticals Inc. From 08/08/22

Advancing Bemnifosbuvir to Late-Stage Development for COVID-19 Following Meetings with U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Emergency Task Force New Data Demonstrate Bemnifosbuvir Retained Antiviral Activity Against Omicron Subvariant In Vitr...

Atea Pharmaceuticals ( NASDAQ: AVIR ) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close. The consensus EPS Estimate is -$0.49 (-2550.0% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS estimates have seen 2...

BOSTON, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that it will host a live conference call and audio webcast on Monday, August 8, 2022, at 4:30 p.m. ET to report financial r...

BOSTON, July 11, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals together with other members o...

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, will present a corporate ove...

Gainers: Elevation Oncology (ELEV) +9%. INMODE  (INMD) +6%. Inspirato Incorporated (ISPO) +5%. Ranger Oil Corporation (ROCC) +5%. Anavex Life Sciences  (AVXL) +5%. Losers: Concert Pharmaceuticals (CNCE) -17%. Chindata Group Holdings Limited (CD) -11%. Conn's (CONN) -7%. Am...

Reviewing its coverage on biotechs with negative enterprise values, Morgan Stanley says that the number of companies on the list with potential catalysts in 2022 has increased to 27 in May from 20 previously. Adding market capitalization to total debt and deducting cash and cash equivalents, ...

Image source: The Motley Fool. Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q1 2022 Earnings Call May 10, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Call Transcri...

Atea Pharmaceuticals, Inc. (AVIR) Q1 2022 Earnings Conference Call May 10, 2022 8:00 a.m. ET Company Participants Jean-Pierre Sommadossi - Founder & CEO Janet Hammond - Chief Development Officer Andrea Corcoran - CFO & EVP, Legal John Vavricka - Chief Commercial Officer Jonae Barnes -...

The following slide deck was published by Atea Pharmaceuticals, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Atea Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation